Replimune Group, Inc.
500 Unicorn Park
Woburn, MA 01801
August 25, 2020
VIA EDGAR AND E-MAIL
United States Securities and Exchange Commission
Division of Corporation Finance
Office of Healthcare & Insurance
100 F Street, N.E.
Washington, D.C. 20549-6010
|
Attention: |
|
Abby Adams |
|
|
|
|
|
Re: |
|
Replimune Group, Inc. Registration Statement on Form S-3 Filed August 11, 2020 |
Dear Ms. Adams:
In accordance with Rule 461 of Regulation C of the General Rules and Regulations under the Securities Act of 1933, as amended, we hereby request acceleration of the effective date of the above-referenced Registration Statement (the “Registration Statement”) of Replimune Group, Inc. We respectfully request that the Registration Statement become effective as of 4:05 p.m., Eastern time, on August 26, 2020 or as soon as practicable thereafter. Once the Registration Statement has been declared effective, please orally confirm that event with our counsel, Morgan, Lewis & Bockius LLP, by calling Benjamin J. Stein at +1 (781) 724-4258.
[Remainder of page intentionally left blank]
|
|
Very truly yours, | |
|
|
| |
|
|
Replimune Group, Inc. | |
|
|
| |
|
|
By: |
/s/ Jean Franchi |
|
|
|
Jean Franchi |
|
|
|
Chief Financial Officer |
|
cc: |
Philip Astley-Sparke, Replimune Group, Inc. |
|
|
Timothy J. Corbett, Morgan, Lewis & Bockius LLP |